Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

The M5 muscarinic acetylcholine receptor third intracellular loop regulates receptor function and oligomerization

  • Borroto Escuela, Dasiel Óscar
  • García-Negredo, Gloria
  • Garriga, Pere
  • Fuxe, Kjell
  • Ciruela, Francisco
Besides some pharmacological, biochemical and biophysical evidences support the contention that muscarinic acetylcholine receptors can form homo- and heterodimers, the existence of specific M3 and M5 muscarinic receptors oligomers in living cells is a new concept. Interestingly, this phenomenon might have relevance in lymphocytic cholinergic function since both T- and B-cells naturally express high levels of these two receptor subtypes. Here, by means of co-immunoprecipitation and bioluminescence resonance energy transfer methods we demonstrated that M3 and M5 muscarinic receptors could form constitutive homo- and heterodimers in transiently transfected HEK-293T cells. Interestingly, this receptor-receptor interaction was unaltered by carbachol treatment but it was affected by the expression of a peptide corresponding to a portion of the third intracellular loop of the M5 muscarinic receptor. In addition, the same peptide was able to abrogate the carbachol-induced mitogen-activated protein kinase phosphorylation and the carbachol-enhanced PHA-induced IL-2 production in derived lymphocytic T cells. Overall, these results suggest that the third intracellular loop of the M5 muscarinic receptor might play a regulatory role in receptor function and heteromerization, thus providing the molecular framework for a potential cholinergic-based therapeutic intervention of the immune system., Ministerio de Ciencia e Innovación (España), European Social Fund (FSE/ESF), Generalitat de Catalunya (Govern de Catalunya)
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

Adenosine-dopamine interactions in the pathophysiology and treatment of cns disorders

  • Fuxe, K.
  • Marcellino, D.
  • Borroto-Escuela, D.O.
  • Guescini, M.
  • Fernández-Dueñas, V.
  • Tanganelli, S.
  • Rivera, A.
  • Ciruela, F.
  • Agnati, L.F.
Adenosine-dopamine interactions in the central nervous system (CNS) have been studied for many years in view of their relevance for disorders of the CNS and their treatments. The discovery of adenosine and dopamine receptor containing receptor mosaics (RM, higher-order receptor heteromers) in the striatum opened up a new understanding of these interactions. Initial findings indicated the existence of A2AR-D2R heterodimers and A1R-D1R heterodimers in the striatum that were followed by indications for the existence of striatal A2AR-D3R and A2AR-D4R heterodimers. Of particular interest was the demonstration that antagonistic allosteric A2A-D2 and A1-D1 receptor-receptor interactions take place in striatal A2AR-D2R and A1R-D1R heteromers. As a consequence, additional characterization of these heterodimers led to new aspects on the pathophysiology of Parkinson's disease (PD), schizophrenia, drug addiction, and l-DOPA-induced dyskinesias relevant for their treatments. In fact, A2AR antagonists were introduced in the symptomatic treatment of PD in view of the discovery of the antagonistic A 2AR-D2R interaction in the dorsal striatum that leads to reduced D2R recognition and Gi/o coupling in striato-pallidal GABAergic neurons. In recent years, indications have been obtained that A2AR-D2R and A1R-D1R heteromers do not exist as heterodimers, rather as RM. In fact, A 2A-CB1-D2 RM and A2A-D 2-mGlu5 RM have been discovered using a sequential BRET-FRET technique and by using the BRET technique in combination with bimolecular fluorescence complementation. Thus, other pathogenic mechanisms beside the well-known alterations in the release and/or decoding of dopamine in the basal ganglia and limbic system are involved in PD, schizophrenia and drug addiction. In fact, alterations in the stoichiometry and/or topology of A 2A-CB1-D2 and A2A-D 2-mGlu5 RM may play a role. Thus, the integrative receptor-receptor interactions in these RM give novel aspects on the pathophysiology and treatment strategies, based on combined treatments, for PD, schizophrenia, and drug addiction., Swedish Medical Research Council, Torsten and Ragnar Söderberg Foundation, Hjärnfonden, Marianne and Marcus Wallenberg Foundation, Ministerio de Ciencia e Innovación (España), Generalitat de Catalunya
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

Impaired M 3 Muscarinic acetylcholine receptor signal transduction through blockade of binding of multiple proteins to its third intracellular loop

  • Borroto Escuela, Dasiel Óscar
  • Correia, Patricia A.
  • Pérez Alea, Mileidys
  • Narváez-Peláez, Manuel
  • Garriga, Pere
  • Fuxe, Kjell
  • Ciruela, Francisco
https://karger.com/pages/rights-and-permissions, Several motifs found in the third intracellular loop of the M 3 muscarinic receptor are critical for G protein activation and scaffold protein interaction. However, how multiprotein complexes form is not fully understood. A minigene encoding the third intracellular loop of the M 3 muscarinic receptor was constructed to explore whether peptides from this intracellular region could act as inhibitors of the muscarinic multiprotein complex formation and signaling. We found that this construct, when co-expressed with the M 3 receptor, has the ability to act as a competitive antagonist of G protein receptors and receptor-scaffold/accessory proteins. Transient transfection of human embryonic kidney-293 cells with DNA encoding the human M 3 and M 5 receptor subtypes results in a carbachol-dependent increase of inositol phosphate. Co-expression of the M 3 third cytoplasmic loop minigene dramatically reduces both carbachol-mediated G protein activation and inositol phosphate accumulation. Minigene expression also abrogates activation of M 3 and M 5 receptor mitogen-activated protein kinases pathway. Furthermore, minigene expression led to reduced AKT activation. These data, together with results of co-immunoprecipitation of different scaffold and kinase proteins, provide experimental evidence for the role for the third cytoplasmic loop of the human M 3 muscarinic receptor in G-protein activation and multiprotein complex formation., Ministerio de Ciencia e Innovación (Gobierno de España), European Social Fund (FSE/ESF), Generalitat de Catalunya (Govern de Catalunya), Swedish Medical Research Council, Torsten and Ragnar Söderberg Foundation